Is biopharmaceuticals an unpopular major?

Yes, it makes sense that biopharmaceutical is an unpopular major. Since 20 10, bioengineering and biotechnology have been listed as red card warning majors by Max Institute, based on employment indicators. After graduation, the jobs of biology-related majors are mainly concentrated in the fields of pharmacy, bioengineering, medical care, new energy and so on.

The average salary is average. Most of the work is concentrated in the north, Guangzhou and Shenzhen. Life pressure is relatively high. Compared with higher vocational college graduates. The advantages of bioengineering undergraduate course are not obvious.

Extended data

Application of biopharmaceuticals in DNA vaccine for type I diabetes mellitus

The DNA vaccine based on B7- 1-PE40KDEL exotoxin fusion gene has recently obtained the international "tripartite" invention patent authorization. This achievement is an original achievement with completely independent intellectual property rights, and it is also the first international "tripartite" invention patent authorization in the field of new therapeutic DNA vaccine in China, that is, this achievement will be patented in the three largest markets in the world (the United States, the European Union and Japan).

Therapeutic DNA vaccine has strong specificity, definite curative effect, good safety and low production cost, and now it has become another new strategic commanding point in the global biopharmaceutical industry after monoclonal antibody drugs. According to reports, the DNA vaccine can effectively prevent and treat type I diabetes in previous animal experiments, correct the disordered cellular and humoral immune response of type I diabetes, repair damaged islet β cells and restore insulin secretion.

Baidu encyclopedia-biology pharmacy